Acquisition and loss of amplified genes: dramatic effects of hormones, tumor promoters and cytotoxic drugs.
We discuss our recent findings in three related areas of the gene amplification field. 1) We have found that tumor-promoting phorbol esters, nonphorbol tumor promoters, and most significantly, mitogenic hormones, such as insulin, vasopressin, and epidermal growth factor (EGF), greatly increase the incidence of methotrexate (MTX) resistance in 3T6 cells under condition of MTX selection. Most of these MTX-resistant cells bear amplified dihydrofolate reductase (DHFR) genes. 2) We have discovered that when mouse cells bearing unstably amplified DHFR genes are grown in the presence of nonlethal concentrations of hydroxyurea (HU), the rate of loss of the DHFR genes from these cells is greatly increased. 3) We have developed a new method for detection and mapping of homologous, repeated and amplified DNA sequences, and have used this method to detect and clone amplified DNA fragments in mammalian cells resistant simultaneously to a number of different drugs.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001483:Base Sequence; D002273:Carcinogens / Q000494:pharmacology*; D004247:DNA / Q000302:isolation & purification; D004261:DNA Replication / Q000187:drug effects; D004351:Drug Resistance; D005784:Gene Amplification / Q000187:drug effects*; D006728:Hormones / Q000494:pharmacology*; D006801:Humans; D006918:Hydroxyurea / Q000494:pharmacology; D007328:Insulin / Q000494:pharmacology; D008727:Methotrexate / Q000494:pharmacology; D051379:Mice; D008934:Mitogens / Q000494:pharmacology; D013755:Tetradecanoylphorbol Acetate / Q000633:toxicity; D013762:Tetrahydrofolate Dehydrogenase / Q000235:genetics
D000970:Antineoplastic Agents; D002273:Carcinogens; D006728:Hormones; D007328:Insulin; D008934:Mitogens; D004247:DNA; D013762:Tetrahydrofolate Dehydrogenase; D013755:Tetradecanoylphorbol Acetate; D006918:Hydroxyurea; D008727:Methotrexate